| Dr Daniel J Politelli, DDS | |
|
1353 Warwick Ave, Warwick, RI 02888-5031 | |
| (401) 463-5480 | |
| (401) 463-7601 |
| Full Name | Dr Daniel J Politelli |
|---|---|
| Gender | Male |
| Speciality | Dentist |
| Location | 1353 Warwick Ave, Warwick, Rhode Island |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013271972 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | 3163 (Rhode Island) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Daniel J Politelli, DDS 1353 Warwick Ave, Warwick, RI 02888-5031 Ph: (401) 463-5480 | Dr Daniel J Politelli, DDS 1353 Warwick Ave, Warwick, RI 02888-5031 Ph: (401) 463-5480 |
News Archive
Each year, more than three million American workers are diagnosed with cancer, leading to high productivity losses that mainly affect smaller companies, reports a study in the December Journal of Occupational and Environmental Medicine, official publication of the American College of Occupational and Environmental Medicine (ACOEM).
An international team, led by researchers from the University of California, San Diego School of Medicine, has discovered that "random" mutations in the genome are not quite so random after all. Their study, to be published in the journal Cell on December 21, shows that the DNA sequence in some regions of the human genome is quite volatile and can mutate ten times more frequently than the rest of the genome. Genes that are linked to autism and a variety of other disorders have a particularly strong tendency to mutate.
Genkyotex, the leading developer of NOX inhibitors to treat oxygen-radical mediated diseases, announced today that Phase I studies have demonstrated excellent safety and tolerability following single and multiple oral doses of GKT137831, the first in class NOX 1 and 4 inhibitor. In addition, GKT137831 demonstrated a favourable pharmacokinetic profile in these subjects.
Capricor, Inc., a privately held biotechnology company focused on regenerative medicine, today announced that the U.S. Food and Drug Administration has approved initiation of its Investigational New Drug (IND) application for the ALLSTAR study, which will use allogeneic cardiac-derived stem cells (CDCs) to treat patients following large myocardial infarctions (MI).
The American Society of Addiction Medicine announces its release of the Standards of Care for the Addiction Specialist Physician. Drafted by a diverse panel of addiction treatment providers, researchers and academicians and clinical outcomes experts, this document enumerates the essential treatment standards that should be met by a physician who manages or oversees the care of a patient with addiction and related disorders.
› Verified 6 days ago
Dr. Kenneth J Rudman, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 35 Veterans Memorial Dr, Warwick, RI 02886 Phone: 401-737-5449 Fax: 401-732-3695 | |
Dr. Martin Metzger, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 55 Jefferson Blvd, Warwick, RI 02888 Phone: 401-781-5610 Fax: 401-781-5622 | |
Kamal Babu Thapaliya, Dentist Medicare: Not Enrolled in Medicare Practice Location: 1000 Bald Hill Rd, Warwick, RI 02886 Phone: 469-739-4258 | |
Dr. Bernard A Kilcline, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 161 Airport Rd, Warwick, RI 02889 Phone: 401-738-2193 Fax: 401-732-5367 | |
Dr. Peri Mutewera, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 50 Lambert Lind Hwy, Warwick, RI 02886 Phone: 401-738-2193 Fax: 401-732-5367 | |
Dr. Paul Sarkis Shamirian, DMD Dentist Medicare: Medicare Enrolled Practice Location: 800 Tollgate Rd, Warwick, RI 02886 Phone: 401-826-2266 |